| 标题 |
205TiP IMPACT: Randomized, multicenter, phase III study evaluating the efficacy of immunotherapy (atezolizumab) plus anti-VEGF therapy (bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma (HCC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:T. Yamashita; Y. Inaba; M. Ikeda; M. Sone; K. Yamakado; et al 出版日期:2023-12-03 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)